{"id":341988,"date":"2021-03-19T12:40:21","date_gmt":"2021-03-19T11:40:21","guid":{"rendered":"http:\/\/kapitalis.com\/tunisie\/?p=341988"},"modified":"2021-03-19T12:42:48","modified_gmt":"2021-03-19T11:42:48","slug":"hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte","status":"publish","type":"post","link":"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/","title":{"rendered":"Hikma n\u2019est plus int\u00e9ress\u00e9 par l\u2019acquisition des activit\u00e9s de GSK en Tunisie et en Egypte"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"http:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2021\/03\/Hikma-Pharmaceuticals.jpg\" alt=\"\" class=\"wp-image-341989\"\/><\/figure>\n\n\n\n<p><em style=\"\"><b>La soci\u00e9t\u00e9 <\/b><\/em><strong><em>pharmaceutique tunisienne Adwya porte \u00e0 la connaissance de ses actionnaires que le laboratoire Hikma Pharmaceuticals a mis fin aux discussions concernant l\u2019acquisition potentielle des activit\u00e9s du laboratoire Glaxo Smith Kline (GSK) en Tunisie et en Egypte.<\/em><\/strong><\/p>\n\n\n\n<!--more-->\n\n\n\n<p>La soci\u00e9t\u00e9 Adwya rappelle que GSK est l\u2019un de ses bailleurs de licences et qu\u2019il \u00e9tait en n\u00e9gociation avec Hikma pour la cession d\u2019une grande partie de son activit\u00e9 pharmaceutique en Tunisie et en Egypte.<\/p>\n\n\n\n<p>Hikma Pharmaceuticals est une entreprise pharmaceutique d&rsquo;origine jordanienne sp\u00e9cialis\u00e9e dans les g\u00e9n\u00e9riques, dont le si\u00e8ge social est situ\u00e9 \u00e0 Londres.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La soci\u00e9t\u00e9 pharmaceutique tunisienne Adwya porte \u00e0 la connaissance de ses actionnaires que le laboratoire Hikma Pharmaceuticals a mis fin aux discussions concernant l\u2019acquisition potentielle des activit\u00e9s du laboratoire Glaxo Smith Kline (GSK) en Tunisie et en Egypte.<\/p>\n","protected":false},"author":8,"featured_media":341989,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[995,2433],"tags":[2810,2379,88486,88487,88485],"class_list":["post-341988","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-economie","category-tunisie","tag-adwya","tag-egypte","tag-glaxo-smith-kline","tag-gsk","tag-hikma-pharmaceuticals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Hikma n\u2019est plus int\u00e9ress\u00e9 par l\u2019acquisition des activit\u00e9s de GSK en Tunisie et en Egypte - Kapitalis<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hikma n\u2019est plus int\u00e9ress\u00e9 par l\u2019acquisition des activit\u00e9s de GSK en Tunisie et en Egypte - Kapitalis\" \/>\n<meta property=\"og:description\" content=\"La soci\u00e9t\u00e9 pharmaceutique tunisienne Adwya porte \u00e0 la connaissance de ses actionnaires que le laboratoire Hikma Pharmaceuticals a mis fin aux discussions concernant l\u2019acquisition potentielle des activit\u00e9s du laboratoire Glaxo Smith Kline (GSK) en Tunisie et en Egypte.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/\" \/>\n<meta property=\"og:site_name\" content=\"Kapitalis\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/KapitalisInfo\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-19T11:40:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-19T11:42:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/kapitalis-logo-fb.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"webmaster kapitalis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@KapitalisInfo\" \/>\n<meta name=\"twitter:site\" content=\"@KapitalisInfo\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"webmaster kapitalis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/\"},\"author\":{\"name\":\"webmaster kapitalis\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#\/schema\/person\/d71f33a9ca44f7bad4698210b480c8e9\"},\"headline\":\"Hikma n\u2019est plus int\u00e9ress\u00e9 par l\u2019acquisition des activit\u00e9s de GSK en Tunisie et en Egypte\",\"datePublished\":\"2021-03-19T11:40:21+00:00\",\"dateModified\":\"2021-03-19T11:42:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/\"},\"wordCount\":123,\"commentCount\":1,\"publisher\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#organization\"},\"image\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Adwya\",\"Egypte\",\"Glaxo Smith Kline\",\"GSK\",\"Hikma Pharmaceuticals\"],\"articleSection\":[\"ECONOMIE\",\"Tunisie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/\",\"url\":\"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/\",\"name\":\"Hikma n\u2019est plus int\u00e9ress\u00e9 par l\u2019acquisition des activit\u00e9s de GSK en Tunisie et en Egypte - Kapitalis\",\"isPartOf\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2021-03-19T11:40:21+00:00\",\"dateModified\":\"2021-03-19T11:42:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/kapitalis.com\/tunisie\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hikma n\u2019est plus int\u00e9ress\u00e9 par l\u2019acquisition des activit\u00e9s de GSK en Tunisie et en Egypte\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#website\",\"url\":\"https:\/\/kapitalis.com\/tunisie\/\",\"name\":\"Kapitalis\",\"description\":\"L&#039;actualit\u00e9 en Tunisie et dans le monde\",\"publisher\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/kapitalis.com\/tunisie\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#organization\",\"name\":\"Kapitalis\",\"url\":\"https:\/\/kapitalis.com\/tunisie\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/Kapitalis-big-size.png\",\"contentUrl\":\"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/Kapitalis-big-size.png\",\"width\":5000,\"height\":1500,\"caption\":\"Kapitalis\"},\"image\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/KapitalisInfo\/\",\"https:\/\/x.com\/KapitalisInfo\",\"https:\/\/www.youtube.com\/channel\/UC-yDYrHyfFBWWZaOw3FPg9Q\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#\/schema\/person\/d71f33a9ca44f7bad4698210b480c8e9\",\"name\":\"webmaster kapitalis\",\"url\":\"https:\/\/kapitalis.com\/tunisie\/author\/webmaster-kapitalis\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hikma n\u2019est plus int\u00e9ress\u00e9 par l\u2019acquisition des activit\u00e9s de GSK en Tunisie et en Egypte - Kapitalis","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/","og_locale":"fr_FR","og_type":"article","og_title":"Hikma n\u2019est plus int\u00e9ress\u00e9 par l\u2019acquisition des activit\u00e9s de GSK en Tunisie et en Egypte - Kapitalis","og_description":"La soci\u00e9t\u00e9 pharmaceutique tunisienne Adwya porte \u00e0 la connaissance de ses actionnaires que le laboratoire Hikma Pharmaceuticals a mis fin aux discussions concernant l\u2019acquisition potentielle des activit\u00e9s du laboratoire Glaxo Smith Kline (GSK) en Tunisie et en Egypte.","og_url":"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/","og_site_name":"Kapitalis","article_publisher":"https:\/\/www.facebook.com\/KapitalisInfo\/","article_published_time":"2021-03-19T11:40:21+00:00","article_modified_time":"2021-03-19T11:42:48+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/kapitalis-logo-fb.png","type":"image\/png"}],"author":"webmaster kapitalis","twitter_card":"summary_large_image","twitter_creator":"@KapitalisInfo","twitter_site":"@KapitalisInfo","twitter_misc":{"\u00c9crit par":"webmaster kapitalis","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/#article","isPartOf":{"@id":"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/"},"author":{"name":"webmaster kapitalis","@id":"https:\/\/kapitalis.com\/tunisie\/#\/schema\/person\/d71f33a9ca44f7bad4698210b480c8e9"},"headline":"Hikma n\u2019est plus int\u00e9ress\u00e9 par l\u2019acquisition des activit\u00e9s de GSK en Tunisie et en Egypte","datePublished":"2021-03-19T11:40:21+00:00","dateModified":"2021-03-19T11:42:48+00:00","mainEntityOfPage":{"@id":"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/"},"wordCount":123,"commentCount":1,"publisher":{"@id":"https:\/\/kapitalis.com\/tunisie\/#organization"},"image":{"@id":"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/#primaryimage"},"thumbnailUrl":"","keywords":["Adwya","Egypte","Glaxo Smith Kline","GSK","Hikma Pharmaceuticals"],"articleSection":["ECONOMIE","Tunisie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/","url":"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/","name":"Hikma n\u2019est plus int\u00e9ress\u00e9 par l\u2019acquisition des activit\u00e9s de GSK en Tunisie et en Egypte - Kapitalis","isPartOf":{"@id":"https:\/\/kapitalis.com\/tunisie\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/#primaryimage"},"image":{"@id":"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/#primaryimage"},"thumbnailUrl":"","datePublished":"2021-03-19T11:40:21+00:00","dateModified":"2021-03-19T11:42:48+00:00","breadcrumb":{"@id":"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/kapitalis.com\/tunisie\/2021\/03\/19\/hikmas-nest-plus-interesse-par-lacquisition-des-activites-de-gsk-en-tunisie-et-en-egypte\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/kapitalis.com\/tunisie\/"},{"@type":"ListItem","position":2,"name":"Hikma n\u2019est plus int\u00e9ress\u00e9 par l\u2019acquisition des activit\u00e9s de GSK en Tunisie et en Egypte"}]},{"@type":"WebSite","@id":"https:\/\/kapitalis.com\/tunisie\/#website","url":"https:\/\/kapitalis.com\/tunisie\/","name":"Kapitalis","description":"L&#039;actualit\u00e9 en Tunisie et dans le monde","publisher":{"@id":"https:\/\/kapitalis.com\/tunisie\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kapitalis.com\/tunisie\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/kapitalis.com\/tunisie\/#organization","name":"Kapitalis","url":"https:\/\/kapitalis.com\/tunisie\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/kapitalis.com\/tunisie\/#\/schema\/logo\/image\/","url":"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/Kapitalis-big-size.png","contentUrl":"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/Kapitalis-big-size.png","width":5000,"height":1500,"caption":"Kapitalis"},"image":{"@id":"https:\/\/kapitalis.com\/tunisie\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/KapitalisInfo\/","https:\/\/x.com\/KapitalisInfo","https:\/\/www.youtube.com\/channel\/UC-yDYrHyfFBWWZaOw3FPg9Q"]},{"@type":"Person","@id":"https:\/\/kapitalis.com\/tunisie\/#\/schema\/person\/d71f33a9ca44f7bad4698210b480c8e9","name":"webmaster kapitalis","url":"https:\/\/kapitalis.com\/tunisie\/author\/webmaster-kapitalis\/"}]}},"_links":{"self":[{"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/posts\/341988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/comments?post=341988"}],"version-history":[{"count":0,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/posts\/341988\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/media\/341989"}],"wp:attachment":[{"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/media?parent=341988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/categories?post=341988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/tags?post=341988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}